Form 4: Roivant Sciences Director Reports Stock Transaction
Insider Transaction (Form 4)
Meghan Fitzgerald, a Director of Roivant Sciences Ltd., reported a transaction in 1,743 shares of common stock on September 10, 2026.
Summary
- Tax/exercise-price withholding: disposed of 1,743 Common Shares at $40.94 ($71,358) on September 10, 2026; holds 41,220 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Meghan Fitzgerald — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Tax/exercise-price withholding | Common Shares | 1,743 | $41 | $71.4K | 41,220 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Tax/exercise-price withholding (1,743 shares) |
Keywords
insider transaction, Form 4, ROIV, Roivant Sciences Ltd., neutral, Meghan Fitzgerald
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.